Arbor Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$721K Buy
601
+228
+61% +$233K 0.08% 63
2026
Q1
$343K Buy
373
+142
+61% +$144K 0.04% 77
2025
Q4
$248K Buy
+231
New +$221K 0.03% 99
2024
Q4
Sell
-237
Closed -$210K 115
2024
Q3
$210K Hold
237
0.03% 113
2024
Q2
$214K Buy
+237
New +$190K 0.03% 97
2020
Q4
Sell
-1,850
Closed -$274K 97
2020
Q3
$274K Sell
1,850
-59
-3% -$9.13K 0.07% 69
2020
Q2
$313K Hold
1,909
0.09% 65
2020
Q1
$265K Buy
1,909
+1
+0.1% +$137 0.09% 66
2019
Q4
$251K Hold
1,908
0.07% 76
2019
Q3
$213K Hold
1,908
0.06% 80
2019
Q2
$211K Hold
1,908
0.07% 75
2019
Q1
$248K Hold
1,908
0.08% 65
2018
Q4
$221K Sell
1,908
-79
-4% -$8.82K 0.08% 52
2018
Q3
$213K Buy
+1,987
New +$199K 0.08% 53

Other funds holding LLY

Arbor Investment Advisors's LLY Position: Q2 2026 in Review

Arbor Investment Advisors increased its Eli Lilly (LLY) stake by 61% in Q2 2026, buying an estimated $233K and bringing the position to 601 shares worth $721K. The position accounts for 0.08% of the portfolio, ranked #63.

Arbor Investment Advisors first reported a position in LLY in Q3 2018 and has held it in 14 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Arbor Investment Advisors held 601 shares of Eli Lilly worth $721K as of Q2 2026.
  • Arbor Investment Advisors bought 228 Eli Lilly shares in Q2 2026, an estimated $233K.
  • Eli Lilly made up 0.08% of Arbor Investment Advisors's portfolio in Q2 2026, its #63 holding.
  • Arbor Investment Advisors first reported a position in Eli Lilly in Q3 2018 and has held it in 14 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Arbor Investment Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.